FLS Playbook Update: Bulls Continue Quell Bearish Efforts 04.28.15

Facebook
Twitter
LinkedIn

[su_heading style=”modern-2-dark” size=”20″] Market Update [/su_heading]

Over the last 48hrs, the market is trading in a sloppy fashion as the key biotech sector is trading all over the map. The bulls are currently doing their best to defend support for the $IBB (biotech ETF) near its 50 DMA line. So far, every time, this market shows a HINT of trouble (selling), the bulls magically show up and aggressively buy stock. It is amazing to watch in real time and would be comical if it wasn’t so important. Typically, this is not healthy action and the market would be much lower but the fact that the Easy Money trade from global central banks is alive and well continues to give this market a very strong bid. Of course, the Fed meeting and Q1 GDP are tomorrow and that could change the near term playing field if sellers emerge. Until the buyers run out of gas, this market continues to deserve the bullish benefit of the doubt.

 

[su_heading style=”modern-1-dark” size=”18″] Positions [/su_heading]

Thankfully, the FLS portfolio continues acting very well. To protect our positions, we are moving a few stops up to breakeven, when and where possible.  Here is a snapshot of the FLS portfolio as of 1pm EST:

  1. The service owns: TSLA +13.50%, HACK +5.82%, SPY +2.09%, AAPL +1.93%, GDX +1.69%, IBB -1.62%, FB – 0.96%

  2. The service will exit: TSLA @ 204.69, HACK @ 28.85, SPY @ 206.98, IBB @ 333.57, GDX @ 19.24,
    AAPL @125.66, FB @ 78.42,

[su_heading style=”modern-1-dark” size=”18″] Working Buy Orders [/su_heading]

There Are No New Buy Orders

Facebook
Twitter
LinkedIn

Here are more articles you may like

Claim Your Free Guide Today

Give us your email and we will give you the tools to change your life. 

FREE 7 DAY EMAIL COURSE

Learn about Early Entry Points & much more...

© ChartYourTrade | Contact us: website@chartyourtrade.com

Disclaimer: All communication from ChartYourTrade is general in nature and for educational and general informational purposes only. Under no circumstance should it be considered personalized investment advice. All our work is general in nature and not specific to any one person. All the information on this site and/or that originates from us, or any of our partners or affiliates, is for educational and informational purposes only and is NOT a recommendation to buy or sell anything. To avoid any conflicts of interest, we do not have a working relationship with any of the companies mentioned in our work. Furthermore, we may have a long, short, or no position in any, or all, of the names that appear in our work and they may change at any time without notice. Investing and trading in capital markets or using margin carries a high level of risk and may not be suitable for all investors. Leverage can work against you as well as for you. Before you decide to invest or trade in capital markets you should carefully consider your investment objectives, level of experience, and risk appetite, among other factors. The possibility exists that you could sustain a loss of some, all, or more of your initial investment and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with capital markets, investing/trading, and seek specific investment advice from an independent financial advisor and other professionals. Remember all the information we provide is for educational and general informational purposes only and is subject to change without notice.

Charts and Data are courtesy of MarketSmith Incorporated. Join MarketSmith here.

Terms of Service